Early and Sustained Reduction in Donor-Specific Antibodies in Desensitized Living Donor Kidney Transplant Recipients: A 3-Year Prospective Study.

Transplant Direct · 2016 · PMC4946491 · PMID 27500255

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

In conclusion, this prospective study of DSA monitoring in desensitized living donor kidney transplant recipients shows a highly significant early reduction in DSA which was sustained up to 3 years posttransplant, excellent 1- and 3- year patient and graft survivals, and a low incidence of AMR.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.